(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...

Mallinckrodt and Endo, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...

As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the ...

The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.

Pope Francis is stable after hospitalization for pneumonia. FDA's Hilary Perkins resigned two days into her new role.

Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...

The agency will send an initial offer for each drug with its maximum fair price proposal no later than June 1, and the drugmakers will have 30 days to either accept it or provide a counteroffer.

(Reuters) -Mallinckrodt and Endo, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced plans Thursday to join forces in a deal valued at $6.7 billion.